Eyal Breitbart

Eyal Breitbart began their work experience as the VP of Research at VBL Therapeutics in January 2006. Eyal held this position until December 2013. Eyal then returned to VBL Therapeutics in February 2022 as the Senior Vice President of Research & Operations until March 2023. In March 2023, Eyal joined Orgenesis Inc. as the Chief Production Officer.

Eyal Breitbart completed their Doctor of Philosophy (Ph.D.) degree at Bar-Ilan University from 1995 to 1999. Eyal then pursued a Post doc Fellowship at Tufts University School of Medicine.